Open to: Academic

UCL Rare Diseases are bringing together industry and UCL academics to explore the unique challenges faced during the development of new medicines/therapies for rare diseases. The workshop will also allow interested parties to present a 3 minute ‘elevator pitch to industry experts. Confirmed speakers include: Dr Kevin Lee, Pfizer, CSO, Orphan and Genetic Diseases, Professor Philip Hawkins, National Amyloidosis Centre, Royal Free Hospital, Dr Derralyn Hughes, Royal Free & University College Medical School, Dr Carlo Russo, Interim Head, Rare Disease R&D, GSK and Dr Jeremy Springhorn, Alexion Pharmacueticals, Inc.

Contact

Ruth Jamieson
r.jamieson@ucl.ac.uk

Links

Register for this event